HealthEquity, Inc. (HQY) HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices. InnovAge Holding Corp. (INNV) InnovAge Holding Corp. manages and provides a range of medical and ancillary […]
Read MoreBuy Price: $71.55 or better Sell Price: TradersPro Sell Signal HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices. The stocks founds in the One Hot Stock category use stocks […]
Read MoreSatsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company’s lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate. STSA $6.8400 -0.4800 % -6.5600 Satsuma Pharmaceuticals Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend […]
Read MoreenVVeno Medical Corporation (NVNO) enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company’s lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. DexCom, […]
Read MoreBuy Price: $84.25 or better Sell Price: TradersPro Sell Signal Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The stocks founds in the One […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $15.2300 0.3600 % 2.4200 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 2.42% […]
Read MoreCogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal […]
Read MoreBuy Price: $12.30 or better Sell Price: TradersPro Sell Signal BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of […]
Read MoreAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. ALT $21.0900 -0.9900 % -4.4800 Altimmune Inc […]
Read MoreBioVie Inc. (BIVI) BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis. Infinity Pharmaceuticals, Inc. (INFI) Infinity Pharmaceuticals, Inc., a biopharmaceutical […]
Read MoreEkso Bionics Holdings, Inc. (EKSO) Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. BioSig Technologies, Inc. (BSGM) BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The […]
Read MoreLantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart. LNTH $84.8200 1.9400 % 2.3400 Lantheus Holdings Sector : Medical Industry : Medical Products […]
Read MoreCatalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. CPRX $13.9500 0.1100 % 0.7900 Catalyst Pharm Inc Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 0.79% […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTIC $6.0800 0.1100 % 1.8400 Cti Biopharm Corp Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 1.84% Wk: 4.47% Mo: […]
Read MoreAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company’s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. ALT $11.2000 -0.5000 % -4.2700 Altimmune Inc […]
Read More